• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

First-time generic approvals (May 2006)

Article

Terconazole vaginal supposit-ories 80 mg (equiv to Terazol 3 vaginal suppositories)

Terconazole vaginal supposit-ories 80 mg (equiv to Terazol 3 vaginal suppositories)
PERRIGO

Pravastatin tablets 10, 20, and 40 mg (equiv to Pravachol tablets)
TEVA

Glipizide extended-release tablets 2.5 mg (equiv to Glucotrol XL extended-release tablets)
WATSON

Pilocarpine tablets 5 and 7.5 mg (equiv to Salagen tablets)
IMPAX

Related Content
© 2024 MJH Life Sciences

All rights reserved.